Tag: companies that drug test

Collections

Drug test collections webinar highlights

November 3, 2015

Our drug test collections expert recently presented a webinar where he shared insights to help you better evaluate your collection services options.

We're There

A drug testing provider you can rely on

October 28, 2015

Our commitment to our customers is simple – we want to show that we’re there when you need us. It's our intentional, every day focus.

News

The dangers of “drugged driving”

October 14, 2015

Public awareness of the dangers of drugged driving is low. To increase awareness, a guide was created to help states act proactively.

News

It’s time to revisit your workplace substance abuse policies

October 12, 2015

All workplace drug-testing programs should be a part of a clearly written, and current, policy that complies with relevant federal and state law.

We're There

I’m There: Bob McCormick

October 9, 2015

Through the unique stories from our team, you'll get a more personal perspective at what that commitment means to them.

We're There

I’m There: Series introduction

October 5, 2015

In this series we will pull back the curtain to reveal the individuals who make up the very fabric of our organization.

News

Find us at SAPAA

September 16, 2015

As a platinum sponsor of this year's SAPAA conference, we couldn't be more excited about this gathering of experts from the drug testing industry.

News

Drug testing trends video

August 14, 2015

A new video highlights key findings from the “Drug Testing Trends” session presented by Dr. Barry Sample at the annual DATIA conference. Watch now.

Hair testing

Quest comments for hair specimen mandatory guidelines

August 5, 2015

HHS published an RFI seeking comments for federally-mandated hair drug testing. Here are our comments in response to the questions posed by HHS.

Oral Fluid testing

Quest comments for oral fluid mandatory guidelines

August 3, 2015

HHS published Oral Fluid Mandatory Guidelines which opened a 60-day comment period. Here are our comments in response to the questions posed by HHS.